Cognitive and motor effects of Immersive Virtual Reality in patients with Neurocognitive Disorder

Faculdade de Medicina da Universidade de São Paulo0 sitesOctober 25, 2023

Overview

No summary available.

Registry

who.int

Start Date

October 25, 2023

End Date

February 1, 2028

Last Updated

2 years ago

Study Type

Intervention

Sponsor

Faculdade de Medicina da Universidade de São Paulo

•Will be included (1\) elderly patients (\>60 years old); (2\) of both genders; (3\) with adequate command of the Portuguese language; that are classified into one of the following two categories: (3\) Mild Neurocognitive Disorder – at least one domain with composite score less than or equal to – 1, but without criteria for dementia; (4\) Mild Major Neurocognitive Disorder with CDR less than 2 and (5\) accepting to participate in the study by signing the Informed Consent Form.

•Individuals with (1\) previous diagnosis of major neurocognitive disorder with CDR greater than or equal to 2 will be excluded; (2\) presence of delirium, psychotic mental disorders, or substance\-related mental disorders according to DSM\-5 criteria; (3\) severe retinal problems or severe visual impairment using corrective lenses; (4\) severe uncorrected hearing deficit; (5\) have decompensated cardiovascular diseases, such as angina, heart failure; (6\) epilepsy; (7\) motion sickness; (8\) experiencing cybersickness during the familiarization game (9\) health problem that makes it impossible to use immersive Virtual Reality; (10\) serious clinical conditions with uncontrolled symptoms or instability and (11\) missing the first 2 consecutive sessions.